Ilex Medical Ltd (TLV:ILX)
Israel · Delayed Price · Currency is ILS · Price in ILA 5,091.00
0.00 (0.00%)
Sep 17, 2026, 5:24 PM IDT
Ilex Medical Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 183.68 | 175.59 | 177.25 | 148.38 | 200.96 | 259.23 |
Short-Term Investments | - | - | 25.87 | 41.25 | 2.74 | - |
Trading Asset Securities | 34.7 | 59.52 | 33.76 | 27.48 | 22 | 25.52 |
Cash & Short-Term Investments | 218.38 | 235.11 | 236.88 | 217.11 | 225.7 | 284.75 |
Cash Growth | -13.92% | -0.75% | 9.11% | -3.81% | -20.74% | 62.02% |
Accounts Receivable | 211.61 | 265.87 | 249.37 | 286.25 | 248.26 | 219.99 |
Other Receivables | 3.97 | 7.06 | 17.56 | 15.57 | 3.04 | 3.73 |
Receivables | 215.58 | 272.93 | 266.93 | 301.82 | 251.3 | 223.72 |
Inventory | 185.44 | 194.21 | 157.89 | 159.68 | 145.8 | 116.32 |
Other Current Assets | 11.75 | 21.42 | 56.77 | 7.39 | 12.02 | 6.93 |
Total Current Assets | 631.15 | 723.66 | 718.47 | 686.01 | 634.83 | 631.72 |
Property, Plant & Equipment | 159.77 | 147.22 | 155.46 | 160.91 | 145.28 | 151.41 |
Long-Term Investments | 84.85 | 54.51 | 53.71 | 57.95 | 72.66 | 32.1 |
Goodwill | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 | - |
Other Intangible Assets | 9.93 | 11.95 | 17.08 | 21.27 | 25.06 | 25.87 |
Long-Term Accounts Receivable | - | 34.53 | 34.91 | 28.51 | 5.73 | 3.75 |
Long-Term Deferred Tax Assets | 6.82 | 5.77 | 7.42 | 8.51 | 6.35 | 6.35 |
Long-Term Deferred Charges | - | - | - | - | 0.04 | 0.08 |
Other Long-Term Assets | 56.4 | 8.08 | 0.01 | 45.95 | 2.23 | 23.8 |
Total Assets | 955.93 | 992.74 | 994.07 | 1,016 | 899.18 | 875.07 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 113.88 | 140.79 | 120.44 | 172.11 | 142.32 | 124.39 |
Current Portion of Long-Term Debt | - | - | 0.31 | 0.41 | 0.56 | 1.13 |
Current Portion of Leases | 12.65 | 13.76 | 12.22 | 11.47 | 12.28 | 11.96 |
Current Income Taxes Payable | 7.25 | 7.4 | 4.5 | 1.4 | 2.22 | 40.39 |
Other Current Liabilities | 72.02 | 93.44 | 130.4 | 93.15 | 68.45 | 62.23 |
Total Current Liabilities | 205.8 | 255.39 | 267.87 | 278.54 | 225.83 | 240.11 |
Long-Term Debt | - | - | - | 0.31 | 0.73 | 1.29 |
Long-Term Leases | 36.39 | 32.83 | 38.81 | 36.07 | 37.99 | 44.36 |
Long-Term Unearned Revenue | 34.34 | 8.17 | 25.28 | 60.33 | 4.11 | - |
Pension & Post-Retirement Benefits | 0.63 | 0.68 | 0.96 | 1.63 | - | - |
Long-Term Deferred Tax Liabilities | 1.73 | 2.41 | 2.55 | 2.94 | 3.15 | 6.72 |
Other Long-Term Liabilities | 6.86 | 8.54 | 12.12 | 12.77 | 14.28 | 7.02 |
Total Liabilities | 285.75 | 308.02 | 347.58 | 392.61 | 286.08 | 299.49 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 12.48 | 12.48 | 12.48 | 12.48 | 12.48 | 12.48 |
Additional Paid-In Capital | 150.5 | 150.5 | 150.5 | 150.5 | 150.5 | 150.5 |
Retained Earnings | 597.96 | 610.8 | 568.58 | 544.92 | 515.41 | 472.39 |
Treasury Stock | -9.2 | -9.2 | -9.2 | -9.2 | -3.49 | - |
Comprehensive Income & Other | -81.55 | -79.85 | -75.86 | -75.19 | -61.79 | -59.79 |
Total Common Equity | 670.18 | 684.71 | 646.49 | 623.51 | 613.1 | 575.57 |
Shareholders' Equity | 670.18 | 684.71 | 646.49 | 623.51 | 613.1 | 575.57 |
Total Liabilities & Equity | 955.93 | 992.74 | 994.07 | 1,016 | 899.18 | 875.07 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 49.04 | 46.6 | 51.35 | 48.27 | 51.55 | 58.74 |
Net Cash (Debt) | 169.34 | 188.51 | 185.53 | 168.84 | 174.15 | 226.02 |
Net Cash Growth | -18.19% | 1.60% | 9.88% | -3.04% | -22.95% | 107.33% |
Net Cash Per Share | 15.14 | 16.85 | 16.58 | 15.09 | 15.44 | 20.04 |
Filing Date Shares Outstanding | 11.16 | 11.19 | 11.19 | 11.28 | 11.28 | 11.28 |
Total Common Shares Outstanding | 11.16 | 11.19 | 11.19 | 11.19 | 11.25 | 11.28 |
Working Capital | 425.35 | 468.27 | 450.6 | 407.47 | 409 | 391.61 |
Book Value Per Share | 60.05 | 61.20 | 57.78 | 55.73 | 54.52 | 51.02 |
Tangible Book Value | 653.25 | 665.76 | 622.4 | 595.24 | 581.04 | 549.7 |
Tangible Book Value Per Share | 58.53 | 59.51 | 55.63 | 53.20 | 51.67 | 48.73 |
Land | - | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
Machinery | - | 260.53 | 254.19 | 244.49 | 212.94 | 193.36 |
Leasehold Improvements | - | 18.32 | 17.78 | 25.19 | 24.04 | 25.51 |